Mark Benton

Mark Benton is an accomplished professional in clinical development and pharmacology with extensive experience spanning over a decade. Currently serving as Vice President of Program Leadership at CRISPR Therapeutics since April 2018, Mark has held multiple leadership roles in clinical development, including Senior Director and Executive Director. Previous positions include Associate Director at Shire and various clinical scientist roles at AbbVie, where significant contributions were made to key clinical studies, regulatory submissions, and scientific oversight of cancer therapies. Mark's earlier career involved research and experimentation in ion channel pharmacology at top-tier institutions like Abbott Laboratories and Northwestern University, where a Doctor of Philosophy in Neuroscience was obtained. Mark's foundational education includes a Bachelor of Science in Biopsychology and Cognitive Science from the University of Michigan.